SUTD-led research sets the groundwork for patient-specific 3D printed meniscus

November 29, 2019

The human knee joint is the largest and complex joint in the body compared to other joints. It has various hard and soft tissue elements to provide stability and proper functioning including the meniscus. The meniscus, a cartilage between the thighbone and the shinbone, acts as a shock absorber to dissipate the body weight and reduce friction during physical activities. Considering, the knee joint is the most used joint in the body, meniscal tears are the most common knee injury due to wear and tear as we age as well as injuries due to sports and trauma.

Meniscal tears can be treated in different ways such as physiotherapy, surgery to remove the torn tissue, replace with allografts, or implants. While meniscal transplants serve as an alternative option, it is technically challenging due to the customization in the sizing required for each person, positioning, securing to the bone, risks of rejection and infection.

Even though a significant amount of work and research has been carried out on prostheses and implants, meniscal implants in particular seem to have been significantly overlooked. It was only in 2015 that the first meniscal got implanted in humans during a clinical trial and more recently in September 2019 that the US' Food and Drug Administration approved the first artificial meniscus based on clinical trial results.

To bridge this research gap, Singapore University of Technology and Design's (SUTD) Medical Engineering and Design (MED) Laboratory collaborated with the University of Miyazaki's Biomechanics Laboratory and developed a novel methodology for the early-stage design assessment and verification of meniscal implants using computational modeling and simulation (refer to image). This initial-design stage development paves the way for the manufacturing of 3D printed meniscus, which will allow for customized, anatomically shaped meniscus for a more optimal fit for the patient when they have a meniscal implant. Their research paper has been published in IEEE.

This new development will provide medical practitioners and industry experts valuable insights into understanding how the remnant hard and soft tissues in the knee joint would react biomechanically should an artificial meniscus be implanted. They can then use this information to evaluate aspects of in vivo performance without subjecting patients as well as animals to potential harm or unnecessary risk. Also, the computational models can be used to evaluate options that would otherwise have been impossible experimentally or clinically.

To demonstrate this, the team developed a comprehensive and detailed computational model of an intact knee joint from the medical images and gait cycle data of a healthy adult volunteer. They validated the developed model with biomechanical experiments using the lower extremity of cadavers. They used the validated model to analyze the biomechanical response of soft-tissues in the knee joint for different meniscus conditions, such as intact meniscus, meniscal root tear, total removal of the meniscus, single material meniscal implant and a shell-core composite meniscal implant. Their results suggested that the composite meniscal implant with a shell-core structure performed better than other meniscus conditions and restored the natural biomechanical response of the joint.

This study could also explain the development of knee osteoarthritis due to increased contact stresses and altered joint kinematics caused by the loss of meniscal tissue. This novel synthetic meniscal implantation approach restores the joint mechanics close to the intact meniscus state and appears to be a promising strategy for treating patients with severe meniscal injuries. The model developed in this study sheds light on the knowledge of joint mechanics after injury or repair, and therefore can also assist in the clinical evaluation of other alternative repair techniques.

"This computational model's ability to study the effects of various meniscal implant configurations in a non-invasive manner provides clinicians and researchers with insights to make more informed decisions and enhance implant designs, positioning, anchoring to the bone as well as the choice of material properties. More importantly, it sets the groundwork for the future of patient-specific 3D printed meniscus for implantation," said lead researcher, Assistant Professor Subburaj Karupppasamy from SUTD's Engineering Product Development pillar.
-end-


Singapore University of Technology and Design

Related Clinical Trial Articles from Brightsurf:

Clinical trial investigates gabapentin for alcohol use disorder
This randomized clinical trial investigated if gabapentin, a drug often used to treat nerve pain, would be useful in the treatment of patients with alcohol use disorder (problem drinking that becomes severe) and a history of alcohol withdrawal symptoms.

Electrical stimulation helps treat constipation in clinical trial
Electrical stimulation benefited women with constipation in a recent clinical trial published in Alimentary Pharmacology & Therapeutics.

Treatment of migraine pain in randomized clinical trial
Adults experiencing a migraine of moderate or severe severity took the drug ubrogepant or placebo and reported if after two hours they were free of pain and of their most bothersome migraine-associated symptom in this randomized clinical trial.

First entirely digital clinical trial encourages physical activity
As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a new study.

HIV vaccine nears clinical trial following new findings
A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar protection as its original version.

Sickle cell drug showing promise in clinical trial
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers.

Meditation goes digital in new clinical trial
Scientists at UC San Francisco have developed a personalized digital meditation training program that significantly improved attention and memory in healthy young adults -- a group already at the peak of brain health -- in just six weeks.

Could blockchain ensure integrity of clinical trial data?
UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain.

Eating crickets can be good for your gut, according to new clinical trial
A new clinical trial shows that consuming crickets can help support the growth of beneficial gut bacteria and that eating crickets is not only safe at high doses but may also reduce inflammation in the body.

Idera Pharmaceuticals presents clinical data from the ILLUMINATE-204 trial of the combination of tilsotolimod and ipilimumab for anti-PD-1 refractory metastatic melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Idera Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with rare cancers and rare diseases, announced results from the ongoing ILLUMINATE-204 trial investigating tilsotolimod, Idera's intratumorally-delivered Toll-like Receptor 9 agonist, in combination with ipilimumab (Yervoy®).

Read More: Clinical Trial News and Clinical Trial Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.